---
schema_version: "secwatch.filing_event.v1"
accession: "0000896622-24-000038"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:50:25.974375+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aptar reports Q3 net income $100M (+19%), adjusted EPS $1.49 (+6%)

## Summary
- Revenue $909M (+2% core sales); Pharma segment core sales +7%, Beauty -6%, Closures +4%.
- Adjusted EBITDA $208M (23% margin); reported EPS $1.48 vs $1.26 prior year.
- Q4 2024 adjusted EPS guidance $1.22-$1.30; full year adjusted EPS outlook $5.34-$5.42, double-digit YoY growth.
- Quarterly dividend $0.45/share, payable Nov 14 to holders of record Oct 24; Board authorized $500M share repurchase program.
- Pharma drug delivery systems grew double digits; Closures margins up ~200 bps YoY.

## SEC filing metadata
- accession: 0000896622-24-000038
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000089662224000038/0000896622-24-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000089662224000038/atr-20241024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896622-24-000038
- JSON: https://secwatch.observer/filing/0000896622-24-000038.json
- Plain text: https://secwatch.observer/filing/0000896622-24-000038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.